Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study
published in: American Heart Journal
date of publication: 2010-03-01
language: English
main subject: atrial fibrillation, vitamin, vitamin K, (E)-phytonadione
Cites articles
There is nothing here
Article - wd:Q34617523